Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Certolizumab pegol (ATC-Code nach WHO: L04AB05)
openAOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Read the notice at vergabe-de ↗
Value
unstated
Published
22 Aug 2025
Deadline
31 Oct 2026, 22:58 GMT · 7d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDEG01
Description
Siehe Kurzbeschreibung
Key facts
- Reference
- 174/2025-OH
- Lots
- 1
- Contact
- Geschäftsbereich Unternehmenssicherheit, Zentrale Vergabestellevergabestelle@plus.aok.de+49 80010590-80071
- Bids opened
- 31 Oct 2026, 22:59 GMT
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- ba910b76-c514-4dbe-a2b9-311411cc8e07
- OCID
- ocds-mnwr74-28943b9a-991d-4955-8de0-28cd79315e27
- First seen
- 23 Aug 2026
- Last updated
- 23 Aug 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/03c7a625-c7f7-4dbe-bcc1-24a4d44504cfThe source notice is authoritative — verify deadlines and documents there before bidding.